Financial Health Report: Clarivate Plc (CLVT)’s Ratios Tell a Tale

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

Clarivate Plc (NYSE: CLVT) closed the day trading at $3.10 down -8.01% from the previous closing price of $3.37. In other words, the price has decreased by -$8.01 from its previous closing price. On the day, 9.77 million shares were traded. CLVT stock price reached its highest trading level at $3.53 during the session, while it also had its lowest trading level at $3.06.

Ratios:

For a better understanding of CLVT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.33. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 0.87. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.89.

On December 15, 2023, Wells Fargo Downgraded its rating to Underweight which previously was Equal Weight but kept the price unchanged to $8.

Jefferies Upgraded its Hold to Buy on October 16, 2023, whereas the target price for the stock was revised from $10 to $8.50.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Snyder Andrew Miles bought 237,176 shares for $4.17 per share. The transaction valued at 989,024 led to the insider holds 787,510 shares of the business.

Bomba Jane L Okun bought 49,750 shares of CLVT for $200,492 on Mar 12 ’25. The Director now owns 49,750 shares after completing the transaction at $4.03 per share. On Mar 03 ’25, another insider, Pritchett Wendell E., who serves as the Director of the company, bought 22,857 shares for $4.38 each. As a result, the insider paid 100,114 and bolstered with 71,835 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLVT now has a Market Capitalization of 2135763584 and an Enterprise Value of 7054904320. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at 2.759 whereas that against EBITDA is 7.34.

Stock Price History:

The Beta on a monthly basis for CLVT is 1.49, which has changed by -0.5866667 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, CLVT has reached a high of $7.67, while it has fallen to a 52-week low of $3.09. The 50-Day Moving Average of the stock is -30.20%, while the 200-Day Moving Average is calculated to be -44.46%.

Shares Statistics:

Over the past 3-months, CLVT traded about 6.07M shares per day on average, while over the past 10 days, CLVT traded about 7086360 shares per day. A total of 691.40M shares are outstanding, with a floating share count of 390.89M. Insiders hold about 43.26% of the company’s shares, while institutions hold 65.50% stake in the company. Shares short for CLVT as of 1741910400 were 43023545 with a Short Ratio of 7.09, compared to 1739491200 on 41417914. Therefore, it implies a Short% of Shares Outstanding of 43023545 and a Short% of Float of 8.0.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.